Study on the Material Basis of Syndromes of Insomnia and the Correlation Between Infrared Image
NCT ID: NCT04141280
Last Updated: 2019-10-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
180 participants
OBSERVATIONAL
2019-10-20
2021-10-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study on Cognitive Impairment of Insomnia Based on MRI
NCT05659511
The Sleepless Brain: Neuroimaging Support for a Differential Diagnosis of Insomnia
NCT02821234
Neural Correlates of Impulsivity in Idiopathic REM Sleep Behavior Disorder
NCT05353855
Unveiling the Neural Mechanisms of 5-HT7 in Sleep Apnea Induced by Arousal Dysregulation
NCT06608888
Investigation of Functional Brain Network in Altered Meditation State With Multimodal Neuroimaging
NCT05020301
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
It has a good effect in treating insomnia with TCM,but there are problems such as strong subjectivity of syndrome differentiation and large difference in efficacy between doctors.
The previous study found that the infrared Image reflects the visceral function of insomnia patients to a certain extent.Modern studies have shown that insomnia is closely related to the dysfunction of functional coordination between the brain's sleep and the arousal center, and neuroactive substances played an important role on it."Syndrome" is the key of clinical diagnosis and treatment of TCM. Investigators believe that the central nervous system imbalance of different syndrome of insomnia has a certain correlation with the infrared Image.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Insomnia group
According to the inclusion and exclusion criteria, 150 patients with insomnia were selected, which were divided into five groups: liver stagnation fire syndrome, phlegm heat syndrome, yin deficiency fire dysfunction syndrome, heart spleen deficiency syndrome and heart deficiency biliary syndrome.
No interventions assigned to this group
Normal group
According to the inclusion and exclusion criteria, 30 normal people were selected.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Meets the diagnostic criteria for ICSD-3 chronic insomnia;
2. PSQI total score \>16 points;
3. Age 18-80 years old;
4. Subjects agree with participate the research;
5. Meets diagnostic criteria for five syndrome types of Chinese medicine insomnia.
* Normal group:
1. Subjects had no insomnia or lacked of sleep in the past month.
2. Blood pressure, blood sugar, and blood lipids are normal;
3. Age 18-80 years old;
4. Subjects agree with participate the research.
Exclusion Criteria
1. Suffering from serious neurological and psychiatric diseases;
2. Suffering from systemic immune diseases, blood system diseases and obvious skin diseases;
3. Having obvious symptoms of coronary heart disease and cerebrovascular disease;
4. fMRI examination contraindications, including those who have undergone cardiac pacemaker implantation, those with grafts or metal foreign bodies, claustrophobia, etc.
5. Unable to complete the tester.
* Normal group:
1. PSQI total score ≥ 7 points;
2. People who have taken drugs that affect sleep in the past week.
3. Suffering from serious neurological and psychiatric diseases;
4. Suffering from systemic immune diseases, blood system diseases and obvious skin diseases;
5. Having obvious symptoms of coronary heart disease and cerebrovascular .
6. fMRI examination contraindications, including those who have undergone cardiac pacemaker implantation, those with grafts or metal foreign bodies, claustrophobia, etc.
7. Unable to complete the tester.
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
China Academy of Chinese Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jun Song
director of science and education department
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hongtao Lei
Role: STUDY_DIRECTOR
Eperimental Research Center,China Academy of Chinese Medical Sciences
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Liu K, Kim J, Kim DW, Zhang YS, Bao H, Denaxa M, Lim SA, Kim E, Liu C, Wickersham IR, Pachnis V, Hattar S, Song J, Brown SP, Blackshaw S. Lhx6-positive GABA-releasing neurons of the zona incerta promote sleep. Nature. 2017 Aug 31;548(7669):582-587. doi: 10.1038/nature23663. Epub 2017 Aug 23.
Blackmer AB, Feinstein JA. Management of Sleep Disorders in Children With Neurodevelopmental Disorders: A Review. Pharmacotherapy. 2016 Jan;36(1):84-98. doi: 10.1002/phar.1686.
Manfridi A, Brambilla D, Mancia M. Sleep is differently modulated by basal forebrain GABA(A) and GABA(B) receptors. Am J Physiol Regul Integr Comp Physiol. 2001 Jul;281(1):R170-5. doi: 10.1152/ajpregu.2001.281.1.R170.
Basner M, Rao H, Goel N, Dinges DF. Sleep deprivation and neurobehavioral dynamics. Curr Opin Neurobiol. 2013 Oct;23(5):854-63. doi: 10.1016/j.conb.2013.02.008. Epub 2013 Mar 20.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ZZ2018015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.